Business Context and Reporting Period
Company: Dr. Reddy's Laboratories Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: May 22, 2018
Reporting Period: Quarter and fiscal year ended March 31, 2018
This filing serves to furnish the U.S. Securities and Exchange Commission with the company's public disclosures regarding results of operations and financial condition for the specified period. The results are presented under International Financial Reporting Standards (IFRS) and Indian Accounting Standards (Ind AS).
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached exhibits (Exhibits 99.1 through 99.4) which are referenced but not included in the input text.
- Revenue/Profit: Not provided in text.
- Cash Flow/Liquidity: Not provided in text.
- Debt: Not provided in text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms that the results for the quarter and year ended March 31, 2018, have been announced and attached as exhibits.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It strictly lists the availability of audited financial results and a press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for management commentary and high-level performance highlights.
- Examine Exhibit 99.2 for IFRS Audited Consolidated Financial Results to verify revenue and profit trends.
- Check Exhibit 99.3 for Ind AS Audited Consolidated Financial Results for local regulatory compliance data.
- Verify Exhibit 99.4 for Ind AS Audited Standalone Financial Results to assess the parent company's specific financial position.
- Confirm the filing date of May 22, 2018, aligns with the company's standard reporting calendar.